Identifying Mortality Risks in Patients with Opioid Use Disorder Using Brief Screening Assessment: Secondary Mental Health Clinical Records Analysis

Overview

Journal Drug Alcohol Depend

Publisher Elsevier

Specialty Psychiatry

Date 2016 May 16

PMID 27179824

Citations 4

Authors

Karolina Magda Bogdanowicz

Robert Stewart

Chin-Kuo Chang

Johnny Downs

Mizanur Khondoker

Hitesh Shetty

John Strang

Richard Derek Hayes

Affiliations

Soon will be listed here.

Abstract

Background: Risk assessments are widely used, but their ability to predict outcomes in opioid use disorder (OUD) treatment remains unclear. Therefore, the aim was to investigate if addiction-specific brief risk screening is effective in identifying high mortality risk groups and if subsequent clinical actions following risk assessment impacts on mortality levels.

Methods: Opioid use disorder (OUD) patients were identified in the South London and Maudsley Case Register. Deaths were identified through database linkage to the national mortality dataset. Cox and competing-risk regression were used to model associations between brief risk assessment domains and all-cause and overdose mortality in 4488 OUD patients, with up-to 6-year follow-up time where 227 deaths were registered. Data were stratified by admission to general mental health services.

Results: All-cause mortality was significantly associated with unsafe injecting (HR 1.53, 95% CI 1.10-2.11) and clinically appraised likelihood of accidental overdose (HR 1.48, 95% CI 1.00-2.19). Overdose-mortality was significantly associated with unsafe injecting (SHR 2.52, 95% CI 1.11-5.70) and clinically appraised suicidality (SHR 2.89, 95% CI 1.38-6.03). Suicidality was associated with a twofold increase in mortality risk among OUD patients who were not admitted to mental health services within 2 months of their risk assessment (HR 2.03, 95% CI 1.67-3.24).

Conclusions: Diagnosis-specific brief risk screening can identify OUD patient subgroups at increased risk of all-cause and overdose mortality. OUD patients, where suicidality is evident, who are not admitted into services are particularly vulnerable.

Citing Articles

Substance Use Disorder and Suicidal Ideation in Rural Maryland.

Ahuja M, Jain M, Mamudu H, Al Ksir K, Sathiyaseelan T, Zare S Chronic Stress (Thousand Oaks). 2024; 8:24705470241268483.

PMID: 39113832 PMC: 11304480. DOI: 10.1177/24705470241268483.

Profiles of Patients with Opioid Use Disorders Presenting a History of Suicidal Ideations and Attempts.

Archambault L, Jutras-Aswad D, Toure E, Artunduaga A, Roy S, Barbeau D Psychiatr Q. 2022; 93(2):637-650.

PMID: 35235127 DOI: 10.1007/s11126-022-09978-3.

Reviewing a Decade of Research Into Suicide and Related Behaviour Using the South London and Maudsley NHS Foundation Trust Clinical Record Interactive Search (CRIS) System.

Bittar A, Velupillai S, Downs J, Sedgwick R, Dutta R Front Psychiatry. 2020; 11:553463.

PMID: 33329090 PMC: 7729078. DOI: 10.3389/fpsyt.2020.553463.

Suicidal motivations reported by opioid overdose survivors: A cross-sectional study of adults with opioid use disorder.

Connery H, Taghian N, Kim J, Griffin M, Rockett I, Weiss R Drug Alcohol Depend. 2019; 205:107612.

PMID: 31627077 PMC: 6929689. DOI: 10.1016/j.drugalcdep.2019.107612.

References

Bogdanowicz K, Stewart R, Broadbent M, Hatch S, Hotopf M, Strang J . Double trouble: Psychiatric comorbidity and opioid addiction-all-cause and cause-specific mortality. Drug Alcohol Depend. 2015; 148:85-92. DOI: 10.1016/j.drugalcdep.2014.12.025. View

Wand T . Investigating the evidence for the effectiveness of risk assessment in mental health care. Issues Ment Health Nurs. 2012; 33(1):2-7. DOI: 10.3109/01612840.2011.616984. View

Perera G, Broadbent M, Callard F, Chang C, Downs J, Dutta R . Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record-derived data resource. BMJ Open. 2016; 6(3):e008721. PMC: 4785292. DOI: 10.1136/bmjopen-2015-008721. View

Mathers B, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M . Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 2013; 91(2):102-23. PMC: 3605003. DOI: 10.2471/BLT.12.108282. View

Kapur N . Management of self-harm in adults: which way now?. Br J Psychiatry. 2005; 187:497-9. DOI: 10.1192/bjp.187.6.497. View

Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M . Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction. 2010; 106(1):32-51. DOI: 10.1111/j.1360-0443.2010.03140.x. View

Merrall E, Kariminia A, Binswanger I, Hobbs M, Farrell M, Marsden J . Meta-analysis of drug-related deaths soon after release from prison. Addiction. 2010; 105(9):1545-54. PMC: 2955973. DOI: 10.1111/j.1360-0443.2010.02990.x. View

Stewart R, Soremekun M, Perera G, Broadbent M, Callard F, Denis M . The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data. BMC Psychiatry. 2009; 9:51. PMC: 2736946. DOI: 10.1186/1471-244X-9-51. View

McCowan C, Kidd B, Fahey T . Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. BMJ. 2009; 338:b2225. PMC: 3273784. DOI: 10.1136/bmj.b2225. View

10.

Harriss L, Hawton K . Suicidal intent in deliberate self-harm and the risk of suicide: the predictive power of the Suicide Intent Scale. J Affect Disord. 2005; 86(2-3):225-33. DOI: 10.1016/j.jad.2005.02.009. View

11.

Chang C, Hayes R, Broadbent M, Fernandes A, Lee W, Hotopf M . All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry. 2010; 10:77. PMC: 2958993. DOI: 10.1186/1471-244X-10-77. View

12.

Neale J . Suicidal intent in non-fatal illicit drug overdose. Addiction. 2000; 95(1):85-93. DOI: 10.1046/j.1360-0443.2000.951859.x. View

13.

Zanis D, Woody G . One-year mortality rates following methadone treatment discharge. Drug Alcohol Depend. 1998; 52(3):257-60. DOI: 10.1016/s0376-8716(98)00097-0. View

14.

Darke S, Ross J . The relationship between suicide and heroin overdose among methadone maintenance patients in Sydney, Australia. Addiction. 2001; 96(10):1443-53. DOI: 10.1046/j.1360-0443.2001.961014438.x. View

15.

Wu C, Chang C, Hayes R, Broadbent M, Hotopf M, Stewart R . Clinical risk assessment rating and all-cause mortality in secondary mental healthcare: the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) Case Register. Psychol Med. 2011; 42(8):1581-90. DOI: 10.1017/S0033291711002698. View

16.

Cantor C, McTaggart P, De Leo D . Misclassification of suicide-the contribution of opiates. Psychopathology. 2001; 34(3):140-6. DOI: 10.1159/000049297. View

17.

Darke S, Ross J . Suicide among heroin users: rates, risk factors and methods. Addiction. 2002; 97(11):1383-94. DOI: 10.1046/j.1360-0443.2002.00214.x. View

18.

Sultana J, Chang C, Hayes R, Broadbent M, Stewart R, Corbett A . Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study. Int J Geriatr Psychiatry. 2014; 29(12):1249-54. DOI: 10.1002/gps.4101. View

19.

Hayes R, Chang C, Fernandes A, Broadbent M, Lee W, Hotopf M . Associations between substance use disorder sub-groups, life expectancy and all-cause mortality in a large British specialist mental healthcare service. Drug Alcohol Depend. 2011; 118(1):56-61. DOI: 10.1016/j.drugalcdep.2011.02.021. View

20.

Hayes R, Chang C, Fernandes A, Begum A, To D, Broadbent M . Associations between symptoms and all-cause mortality in individuals with serious mental illness. J Psychosom Res. 2012; 72(2):114-9. DOI: 10.1016/j.jpsychores.2011.09.012. View